Accord BioPharma, Inc. Announces Completion Of UDENYCA® (pegfilgrastim-cbqv) Franchise Acquisition From Coherus ...
Finalization of acquisition reinforces Accord BioPharma and Intas' commitment to growth in the U.S. biosimilar market Raleigh, NC /PRNewswire/ - Accord BioPharma, Inc., the U.S. specialty division of Intas Pharmaceuticals, Ltd., focused on the …